Renaissance Technologies’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $104K | Buy |
+10,200
| New | +$104K | ﹤0.01% | 3294 |
|
2024
Q4 | – | Sell |
-13,700
| Closed | -$140K | – | 3813 |
|
2024
Q3 | $140K | Sell |
13,700
-33,300
| -71% | -$341K | ﹤0.01% | 3197 |
|
2024
Q2 | $332K | Sell |
47,000
-63,900
| -58% | -$452K | ﹤0.01% | 2868 |
|
2024
Q1 | $1.53M | Sell |
110,900
-77,600
| -41% | -$1.07M | ﹤0.01% | 2211 |
|
2023
Q4 | $1.73M | Sell |
188,500
-191,300
| -50% | -$1.76M | ﹤0.01% | 2044 |
|
2023
Q3 | $2.3M | Buy |
379,800
+36,100
| +11% | +$218K | ﹤0.01% | 1774 |
|
2023
Q2 | $2.67M | Sell |
343,700
-400
| -0.1% | -$3.1K | ﹤0.01% | 1818 |
|
2023
Q1 | $1.96M | Buy |
344,100
+27,300
| +9% | +$156K | ﹤0.01% | 2040 |
|
2022
Q4 | $1.87M | Sell |
316,800
-84,600
| -21% | -$498K | ﹤0.01% | 2113 |
|
2022
Q3 | $1.28M | Sell |
401,400
-46,469
| -10% | -$149K | ﹤0.01% | 2345 |
|
2022
Q2 | $2.01M | Buy |
447,869
+228,769
| +104% | +$1.02M | ﹤0.01% | 2193 |
|
2022
Q1 | $1.17M | Buy |
219,100
+192,800
| +733% | +$1.03M | ﹤0.01% | 2629 |
|
2021
Q4 | $387K | Buy |
+26,300
| New | +$387K | ﹤0.01% | 3209 |
|